معرفی
Olayemi O. Adeoye, MBBS, PhD, MPH holds dual academic appointments at Loma Linda University as Assistant Professor in the Physiology Division of the School of Medicine and Associate Professor in the Pharmaceutical and Administrative Sciences department of the School of Pharmacy. His career spans clinical medicine, public health, and physiological research with a focus on vascular adaptation mechanisms.
His educational background includes:
- MBBS (Bachelor of Medicine & Surgery) from University of Lagos (2004)
- Postbaccalaureate Certificate from Loma Linda University (2007)
- MPH (Master of Public Health) from Loma Linda University (2008)
- PhD in Physiology from Loma Linda University (2013)
Adeoye's research centers on vascular smooth muscle responses to hypoxia, particularly in fetal development and pregnancy contexts. His work investigates cytochrome P450 regulation during pregnancy, glucocorticoid receptor homeostasis in obese pregnancies, and cerebrovascular adaptation mechanisms. Current projects include molecular markers of steroid sensitivity in fetal cells (2020-2025) and the Federal Hispanic Center of Excellence in Pharmacy (2022-2027). His 22 publications since 2010 demonstrate consistent contributions to vascular physiology, with recent work expanding into clinical guideline evaluation and cancer pharmacology.
His scholarly output reveals strong focus areas:
- Chronic hypoxia effects on fetal cerebrovascular function (2013-2017)
- VEGF receptor-mediated vascular remodeling (2010-2014)
- Neuropeptide Y and sympathetic nervous system roles in hypoxic adaptation (2014-2015)
- Recent expansion into pregnancy-related metabolic research (2023-2024)
Adeoye actively participates in professional development through conferences including Experimental Biology (2018), Meharry Translational Research Center Health Disparities Conference (2016), and Federation of Societies of Experimental Biology meetings. His teaching portfolio includes foundational biomedical science courses (RXPS 542/783) across multiple summer sessions from 2020-2025, reflecting commitment to medical and pharmacy education.
